loader

World Tenders & Procurement Opportunities

277852- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient formoterol/glycopyrronium/budesonide (ATC code according to WHO: R03AL11)

World Biggest Tenders Source

This tender with title 277852- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient formoterol/glycopyrronium/budesonide (ATC code according to WHO: R03AL11) has been published on Bidding Source portal dated 05 May 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

277852- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient formoterol/glycopyrronium/budesonide (ATC code according to WHO: R03AL11)
Invitation for Bids
277852
Germany
5 May 2025
30 Jun 2027
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

280134-Awarded - Germany – Pharmaceutical products – Cancellation of the open house procedure for drug discount agreements Lamotrigine, ATC N03AX09 Germany 275823- Germany – Pharmaceutical products – Open framework agreement on pharmaceutical discounts pursuant to Section 130a Paragraph 8 of the Social Code Book V with the option to join at any time, so-called approval model 2025-04 Germany 276582-Awarded - Germany – Pharmaceutical products – R8451_75 EA DBS AM Pantoprazol / Ciprofloxacin Germany 271454- Germany – Pharmaceutical products – Open-House drug discount contracts according to Section 130a Paragraph 8c SGB V Trastuzumab, ATC L01FD01 - Contract regions Lower Saxony, Bremen and Saxony-Anhalt Germany 270479- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 or 130c Paragraph 1 SGB V for the period from 01.06.2025 to 31.05.2027 Germany 269767-Awarded - Germany – Pharmaceutical products – B/E2DW/QG137: LEVOCABASTIN 0,05MG/0,1ML NASENSPRAY Germany 262192-Awarded - Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu der Wirkstoffkombination Vilanterol und Umeclidiniumbromid Germany 252730- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tianeptin, ATC N06AX14 für die Zeit 01.06.2025 - 31.05.2027 (zzgl. Verlängerungsoption 1x12 Monate) Germany 252845- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoietin, ATC B03XA01 für die Zeit 01.06.2025 - 31.05.2027 (zzgl. Verlängerungsoption 1x12 Monate) Germany 255277- Germany – Pharmaceutical products – Abschluss nicht exkl. AM-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Glatirameracetat in der Darreichungsform PEN (ATC-Code nach WHO: L03AX13) Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans